Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2015 1
2016 1
2017 1
2019 2
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Second nationwide anti-tuberculosis drug resistance survey in Namibia.
Ruswa N, Mavhunga F, Roscoe JC, Beukes A, Shipiki E, van Gorkom J, Sawadogo S, Agolory S, Menzies H, Tiruneh D, Makumbi B, Bayer B, Zezai A, Campbell P, Alexander H, Kalisvaart N, Forster N. Ruswa N, et al. Int J Tuberc Lung Dis. 2019 Jul 1;23(7):858-864. doi: 10.5588/ijtld.18.0526. Int J Tuberc Lung Dis. 2019. PMID: 31439119 Free PMC article. Clinical Trial.
Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia.
Sagwa EL, Ruswa N, Mavhunga F, Rennie T, Leufkens HG, Mantel-Teeuwisse AK. Sagwa EL, et al. Among authors: Ruswa N. Patient Prefer Adherence. 2016 Nov 23;10:2369-2377. doi: 10.2147/PPA.S116860. eCollection 2016. Patient Prefer Adherence. 2016. PMID: 27920503 Free PMC article.
Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.
Sagwa EL, Ruswa N, Mavhunga F, Rennie T, Leufkens HG, Mantel-Teeuwisse AK. Sagwa EL, et al. Among authors: Ruswa N. BMC Pharmacol Toxicol. 2015 Dec 10;16:36. doi: 10.1186/s40360-015-0036-7. BMC Pharmacol Toxicol. 2015. PMID: 26654443 Free PMC article.
Feedback